Why the Balkans?
Southeast Europe has growing demand for advanced medical diagnostics but limited local access to clinical-grade genomic testing — patients have historically traveled abroad for services like hereditary cancer panels and pharmacogenomics. After successfully launching in Slovenia in mid-2025, Gene Matrix AI expanded into Serbia, Bosnia and Herzegovina, North Macedonia, and Azerbaijan, building local infrastructure instead of shipping samples across continents.
The Partner-Laboratory Network
Our regional hub is anchored in Belgrade. In each country we operate through local partnerships rather than remote-only service:
| Partner Type | Role In The Network |
|---|---|
| Leading hospitals & clinics | Sample collection and clinical integration, so testing fits existing care pathways |
| Local laboratories | Initial processing and logistics under Gene Matrix quality agreements |
| Medical universities | Clinician training and research collaboration through the Gene Matrix Academy |
| Health ministries | Regulatory compliance and reimbursement-pathway development |
Services Available in the Region
GeneCancer™
The 108-gene hereditary cancer panel — BRCA1/2, Lynch syndrome, TP53, and 100+ more genes covering 15+ cancer types.
GeneCancer →GenePGx™
230+ genes covering 700+ medications with CPIC/FDA/DPWG-aligned guidance — one test informs prescribing for life.
GenePGx →GeneCore™
130+ genes across 6 health categories — cardiovascular, metabolic, immune, detoxification, bone, and cognitive function.
GeneCore →GeneHealth™
95+ genes across cardiovascular, metabolic, hormonal, longevity, and organ-health categories for preventive screening.
GeneHealth →How Ordering Works for the Region
- Order: online through genematrix.io or via a partner clinic — our regional team confirms the nearest collection option.
- Collection: at a partner hospital or clinic, or by kit where regional logistics allow.
- Processing: local partner laboratories handle initial processing and logistics; analysis runs on CLIA-validated panels under the Gene Matrix quality system at up to 99.9% analytical accuracy.
- Results: dual-reviewed reports delivered through the secure portal in 5–7 days from lab receipt, with genetic-counseling access for positive results.
Training the Next Generation of Genomic Clinicians
Through the Gene Matrix Academy program, we train local healthcare providers on interpreting genetic test results and integrating precision medicine into clinical practice. More than 200 regional physicians have already completed the certification program — because a test only changes outcomes when a clinician can act on it.
Looking Ahead
The Balkan expansion is the beginning of our Southeast European network. Launches in Croatia, Montenegro, Albania, and Bulgaria are planned for Q3 2026. Qualified partners interested in owning a territory can explore the Gene Matrix franchise model — 40+ territories are available across the Balkans, EU, and Africa.
FAQs
Yes. Gene Matrix AI operates in Serbia through a partner-laboratory network anchored in Belgrade, with regional coverage extending to Bosnia and Herzegovina, North Macedonia, and Azerbaijan. Croatia, Montenegro, Albania, and Bulgaria launches are planned for Q3 2026.
The full suite: GeneCancer (108-gene hereditary cancer panel), GenePGx (230+ genes covering 700+ medications), GeneCore (130+ genes across 6 health categories), and GeneHealth (95+ wellness and longevity genes) — with the remaining panels available through the membership where regional logistics allow.
Order online or through a partner clinic. Collection happens at a partner hospital or clinic (or by kit where available); local partner laboratories handle initial processing and logistics, and analysis and dual review run under the Gene Matrix quality system at up to 99.9% analytical accuracy. Results are delivered through the secure portal in 5–7 days from lab receipt.
Yes — the same CLIA-validated panels, batch controls, and dual-review process apply at every location. Partner laboratories operate under Gene Matrix quality agreements, and our Gene Matrix Academy has certified 200+ regional physicians on results interpretation.